OpenAI's GPT-5.2 derived a new formula for gluon interactions, overturning assumptions of zero amplitude and advancing theoretical physics.

Wikipedia has thousands of list articles. Some of those lists catalog other lists. And one article, "List of lists of lists," ...

The Ethereum co-founder says that prediction markets and creator DAOs would reward inherent value, rather than celebrity or ...

Rock Dept., author Niko Stratis writes about bagging groceries and what “Slide” taught her about the painful weight of first crushes.

OpenAI’s GPT-5.2 collaborated with leading physicists to derive and formally prove new results on gluon scattering amplitudes ...

In NBC Select’s For What It’s Worth podcast, editors discuss the top shopping trends of 2026 across health, wellness, tech, fashion and travel.

Recursion Pharmaceuticals (RXRX) has been drawing attention after recent trading, with the stock closing at $4.67. Investors are weighing this price against the company’s clinical pipeline and ongoing ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

A marriage of formal methods and LLMs seeks to harness the strengths of both.

At the Detroit Free Press Breakfast Club Series on Tuesday, automotive leaders Mark Reuss, of General Motors, and Roger Penske, a racing executive and business man, discussed the automotive industry.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...